TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Chiron Pharmasynth AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
10,392
|
6,946
|
6,589 |
Financial expenses |
88
|
100
|
92 |
Earnings before taxes |
1,337
|
2,867
|
3,499 |
Total assets |
20,104
|
19,044
|
15,325 |
Current assets |
20,104
|
19,044
|
15,315 |
Current liabilities |
7,686
|
7,284
|
5,109 |
Equity capital |
12,418
|
11,760
|
10,215 |
- share capital |
1,254
|
1,323
|
1,256 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
61.8%
![]() |
61.8%
|
66.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
12.9%
|
41.3%
|
53.1% |
Return on assets (ROA) |
7.1%
|
15.6%
|
23.4% |
Current ratio |
261.6%
|
261.4%
|
299.8% |
Return on equity (ROE) |
10.8%
|
24.4%
|
34.3% |
Change turnover |
3,811
|
2
|
-1,178 |
Change turnover % |
58%
|
0%
|
-15% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.